Clinical trials
Blood Cancer clinical trials
Below are recruiting blood cancer clinical trials, each written for real people, not researchers. We’re tracking 478 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05076500Recruiting
How radiotherapy changes a tumor’s immune response
This study looks at how a tumor’s immune system responds when you receive radiotherapy. It involves taking a planned pre-treatment biopsy so researchers can study immune and tumor changes and see if radiotherapy affects them.
ManchesterAges 18 years+ - NCT05082961Recruiting
Blood immune markers and brain radiation after head/neck surgery
This study looks at immune system signals in your blood during and after postoperative radiation therapy for certain head and neck cancers involving the brain or skull base. Researchers want to see whether these “immune markers” relate to treatment response or side effects.
CaenAges 18 years+ - NCT05119244Recruiting
Study of environment factors in lung cancer
This study looks at how environmental factors may relate to lung cancer in adults. If you are between 18 and 59 and were treated for primary lung cancer at a participating hospital, you may be able to join.
Le Plessis-RobinsonAges 18–59 - NCT05306912Recruiting
Test gene analysis on liquid from a lung biopsy
This study looks at special lab tests (molecular analysis) done on liquid taken during a bronchoscopy to better understand lung nodules. It may help doctors learn more about what these nodules are, using samples from the procedure.
Toulouse, OccitanieAges 18 years+ - NCT05324553Recruiting
Using patient tumor samples to build lab models
This study uses tumor tissue from real patients to create lab models that can help researchers test treatments. You might be able to join if you need a biopsy or surgery for care and it’s safe to collect a small amount of tissue for research.
Rochester, MinnesotaAges 18 years+ - NCT06033183Recruiting
Study of radiation sensitivity in children with cancer
This study looks at how children's bodies respond to radiation therapy for certain cancers. By analyzing blood samples, researchers hope to learn why some children experience more side effects, which could help personalize future treatments.
CaenAges 3–18 - NCT05462613RecruitingPhase 2/Phase 3
Regorafenib plus aspirin then standard chemo for metastatic bowel cancer
This trial tests whether adding regorafenib and low-dose aspirin before standard chemotherapy can slow metastatic colorectal cancer after it has progressed on prior treatment. It may help by trying a different cancer-fighting approach earlier, followed by the usual chemo plan.
BesançonAges 18 years+ - NCT05984875Recruiting
Immune system study for ovarian cancer
This study looks at how the immune system works in people with epithelial ovarian cancer. It aims to understand the immune landscape around the tumor, which could lead to better treatments in the future.
BellinzonaAges 18 years+ - NCT00353483Recruiting
Testing treatment before or after breast cancer surgery
This trial studies how different cancer treatments given before or after standard therapy affect breast cancer cells in the blood and bone marrow. It may help doctors better understand how treatments work throughout the body, not just where the tumor is.
St Louis, MissouriAges 18 years+ - NCT06717334Recruiting
Lung cancer screening for people with unexplained weight loss
This study tests if low-dose CT scans can find early lung cancer in people who have unexplained weight loss. It aims to see if weight loss could be a sign that makes screening more useful.
Basking Ridge, New JerseyAges 50–80 - NCT05051722Recruiting
Test DNA blood and tissue markers to detect gynecologic cancers
This study looks for “methylated DNA markers” (special DNA patterns) to help detect endometrial, ovarian, and cervical cancers, and to support doctors around planned procedures. It may help find cancer earlier or better sort out who needs closer treatment.
Phoenix, ArizonaAges 18 years+ - NCT01084785Recruiting
Banking blood samples from people with cancer
This study collects and stores blood and protein samples from people with cancer to help future research. You may be asked to return for follow-up appointments so the researchers can link your samples to health outcomes.
Maastricht, LimburgAges 18 years+ - NCT07197723Recruiting
Study of decision making about prostate cancer risk
This study looks at how men with a BRCA1/2 gene change make decisions about their health and prostate cancer risk. Participants will fill out surveys to help researchers understand these choices.
New York, New YorkAges 45–70 - NCT07155616Enrolling by invitation
Blood flow measurement from CT scan before Whipple surgery
This study uses a computer tool to measure blood flow in the arteries from your CT scan before a Whipple procedure. It may help doctors better plan your surgery.
Barcelona, BarcelonaAges 18 years+ - NCT00242723Recruiting
Looking at cell changes in lung, esophagus, and chest cancers
This study collects blood, urine, and tissue samples from people with lung, esophageal, or other chest cancers to look at cell changes. It does not test a new treatment—instead, it aims to better understand these cancers through research.
Bethesda, MarylandAges 2–120 - NCT01441089Recruiting
Donate blood for genetic testing in an NIH research study
This study collects blood from people already in an NIH (National Institutes of Health) clinical research program to run genetic tests. It may help researchers understand cancer and related inherited conditions by studying DNA changes.
Bethesda, MarylandAges 3 years+ - NCT06153147Recruiting
Kidney & blood pressure in childhood cancer survivors
This study looks at kidney health and blood pressure in childhood cancer survivors. If you finished high-risk cancer therapy about 3 years ago, researchers want to see how your kidneys and blood pressure are doing now.
Toronto, OntarioAges Up to 19 years - NCT06217900Recruiting
Blood test for early detection of multiple cancers (PROFOUND)
This study is testing a new blood test that may help find multiple types of cancer early. It compares blood samples from people with newly diagnosed cancer to those without cancer.
Beijing, Beijing MunicipalityAges 40–74 - NCT03680677Recruiting
Checking frailty to guide treatment in older blood cancer patients
This study checks “frailty” (how strong and able you are to function) to help choose better treatment for people age 60+ with certain blood cancers like acute leukemia or MDS. It may help clinicians tailor care before major treatments like transplant or CAR T-cell therapy.
Philadelphia, PennsylvaniaAges 60 years+ - NCT03819829Recruiting
Blood sampling study for healthy adults’ immune responses
This study takes small blood samples to learn how the immune system works in healthy people. It may help researchers better understand immune biology for future treatments, while you help by participating in regular research blood draws.
AmsterdamAges 36 years+ - NCT04224064Recruiting
Blood test to help diagnose and predict liposarcoma
This study looks for a new blood test marker that may help doctors diagnose liposarcoma and estimate how it may behave over time. You may be asked for a blood sample and consent, and the study may follow you to see how well the test works.
MontpellierAges 18 years+ - NCT06904482RecruitingPhase 2
Stem cell transplant with half-matched donor and cord blood
This trial tests a new way to do a stem cell transplant for people with hard-to-treat blood cancers. It combines a half-matched family donor (haploidentical) with a cord blood unit to help the transplant work better.
Cleveland, OhioAges 18 years+ - NCT06192875Recruiting
Blood test for early cancer detection: the NOMAD study
This study is testing a new blood test to look for early signs of cancer in people without a past cancer diagnosis. You would give blood, urine, and saliva samples to help researchers see if the test works well.
Rochester, MinnesotaAges 18 years+ - NCT06320717Recruiting
AI-guided pre-surgery treatment for pancreatic cancer
This study tests how well an AI tool can guide which pre-surgery treatment is best for people with pancreatic cancer that can be removed. It uses your tumor's genetic fingerprint to choose the most effective therapy.
Buffalo, New YorkAges 18 years+
Hear when a new Blood Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for blood cancer?
- Yes. Clin2 currently lists 478 recruiting blood cancer studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a blood cancer trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a blood cancer trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.